Skp2 regulates Myc protein stability and activity

Molecular Cell

Volumn 11, Issue 5, 2003, Pages 1177-1188

  Kim, So Young ^a,b,c   Herbst, Andreas ^a   Tworkowski, Kathryn A ^a,b   Salghetti, Simone E ^a   Tansey, William P ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; LIGASE; MYC PROTEIN; ONCOPROTEIN; PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; UNCLASSIFIED DRUG;

ARTICLE; EMBRYO; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

EID: 0037648338     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00173-4     Document Type: Article

References (53)

1. Atchley W.R., Fitch W.M. Myc and Max. molecular evolution of a family of proto-oncogene products and their dimerization partner Proc. Natl. Acad. Sci. USA. 92:1995;10217-10221.
2. Bai C., Sen P., Hofmann K., Ma L., Goebl M., Harper J.W., Elledge S.J. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell. 86:1996;263-274.
3. Barral Y., Jentsch S., Mann C. G1 cyclin turnover and nutrient uptake are controlled by a common pathway in yeast. Genes Dev. 9:1995;399-409.
4. Bello-Fernandez C., Packham G., Cleveland J.L. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA. 90:1993;7804-7808.
5. Bhatia K., Huppi K., Spangler G., Siwarski D., Iyer R., Magrath I. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat. Genet. 5:1993;56-61.
6. Bryant G.O., Martel L.S., Burley S.K., Berk A.J. Radical mutations reveal TATA-box binding protein surfaces required for activated transcription in vivo. Genes Dev. 10:1996;2491-2504.
7. Bush A., Mateyak M., Dugan K., Obaya A., Adachi S., Sedivy J., Cole M. c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. Genes Dev. 12:1998;3797-3802.
8. Carrano A.C., Eytan E., Hershko A., Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1:1999;193-199.
9. Coller H.A., Grandori C., Tamayo P., Colbert T., Lander E.S., Eisenman R.N., Golub T.R. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc. Natl. Acad. Sci. USA. 97:2000;3260-3265.
10. Conklin D.S., Kung C., Culbertson M.R. The COT2 gene is required for glucose-dependent divalent cation transport in Saccharomyces cerevisiae. Mol. Cell. Biol. 13:1993;2041-2049.
11. Eilers M., Picard D., Yamamoto K.R., Bishop J.M. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature. 340:1989;66-68.
12. Fields S., Jang S.K. Presence of a potent transcription activating sequence in the p53 protein. Science. 249:1990;1046-1049.
13. Flinn E.M., Busch C.M.C., Wright A.P.H. myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome. Mol. Cell. Biol. 18:1998;5961-5969.
14. Frank S.R., Schroeder M., Fernandez P., Taubert S., Amati B. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev. 15:2001;2069-2082.
15. Grandori C., Cowley S.M., James L.P., Eisenman R.N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16:2000;653-699.
16. Gregory M.A., Hann S.R. c-Myc proteolysis by the ubiquitin-proteasome pathway. stabilization of c-Myc in Burkitt's lymphoma cells Mol. Cell. Biol. 20:2000;2423-2435.
17. Groth A., Weber J.D., Willumsen B.M., Sherr C.J., Roussel M.F. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases. J. Biol. Chem. 275:2000;27473-27480.
18. Gstaiger M., Jordan R., Lim M., Catzavelos C., Mestan J., Slingerland J., Krek W. Skp2 is oncogenic and overexpressed in human cancers. Proc. Natl. Acad. Sci. USA. 98:2001;5043-5048.
19. Guo Q.M., Malek R.L., Kim S., Chiao C., He M., Ruffy M., Sanka K., Lee N.H., Dang C.V., Liu E.T. Identification of c-myc responsive genes using rat cDNA microarray. Cancer Res. 60:2000;5922-5928.
20. Hann S.R., Eisenman R.N. Proteins encoded by the human c-myc oncogene. differential expression in neoplastic cells Mol. Cell. Biol. 4:1984;2486-2497.
21. Imhof M.O., McDonnell D.P. Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors. Mol. Cell. Biol. 16:1996;2594-2605.
22. Koepp D.M., Schaefer L.K., Ye X., Keyomarsi K., Chu C., Harper J.W., Elledge S.J. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science. 294:2001;173-177.
23. Land H., Parada L.F., Weinberg R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature. 304:1983;596-602.
24. Latres E., Chiarle R., Schulman B.A., Pavletich N.P., Pellicer A., Inghirami G., Pagano M. Role of the F-box protein Skp2 in lymphomagenesis. Proc. Natl. Acad. Sci. USA. 98:2001;2515-2520.
25. Lewis B.C., Shim H., Li Q., Wu C.S., Lee L.A., Maity A., Dang C.V. Identification of putative c-Myc-responsive genes. characterization of rcl, a novel growth-related gene Mol. Cell. Biol. 17:1997;4967-4978.
26. Littlewood T.D., Hancock D.C., Danielian P.S., Parker M.G., Evan G.I. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1995;1686-1690.
27. Marti A., Wirbelauer C., Scheffner M., Krek W. Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat. Cell Biol. 1:1999;14-19.
28. Martins C.P., Berns A. Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesis. EMBO J. 21:2002;3739-3748.
29. Mateyak M.K., Obaya A.J., Adachi S., Sedivy J.M. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8:1997;1039-1048.
30. McMahon S.B., Van Buskirk H.A., Dugan K.A., Copeland T.D., Cole M.D. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell. 94:1998;363-374.
31. Mendez J., Zou-Yang X.H., Kim S.Y., Hidaka M., Tansey W.P., Stillman B. Human origin recognition complex large subunit is degraded by ubiquitin-mediated proteolysis after initiation of DNA replication. Mol. Cell. 9:2002;481-491.
32. Molinari E., Gilman M., Natesan S. Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo. EMBO J. 18:1999;6439-6447.
33. Mumberg D., Muller R., Funk M. Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene. 156:1995;119-122.
34. Nawaz Z., Lonard D.M., Smith C.L., Lev-Lehman E., Tsai S.Y., Tsai M.J., O'Malley B.W. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell. Biol. 19:1999;1182-1189.
35. Palmieri S., Kahn P., Graf T. Quail embryo fibroblasts transformed by four v-myc-containing virus isolates show enhanced proliferation but are non tumorigenic. EMBO J. 2:1983;2385-2389.
36. Pham A.D., Sauer F. Ubiquitin-activating/conjugating activity of TAFII250, a mediator of activation of gene expression in Drosophila. Science. 289:2000;2357-2360.
37. Prendergast G.C. Mechanisms of apoptosis by c-Myc. Oncogene. 18:1999;2967-2987.
38. Pulverer B.J., Fisher C., Vousden K., Littlewood T., Evan G., Woodgett J.R. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene. 9:1994;59-70.
39. Reilly P.T., Herr W. Spontaneous reversion of tsBN67 cell proliferation and cytokinesis defects in the absence of HCF-1 function. Exp. Cell Res. 277:2002;119-130.
40. Saleh A., Collart M., Martens J.A., Genereaux J., Allard S., Cote J., Brandl C.J. TOM1p, a yeast hect-domain protein which mediates transcriptional regulation through the ADA/SAGA coactivator complexes. J. Mol. Biol. 282:1998;933-946.
41. Salghetti S.E., Kim S.Y., Tansey W.P. Destruction of Myc by ubiquitin-mediated proteolysis. cancer-associated and transforming mutations stabilize Myc EMBO J. 18:1999;717-726.
42. Salghetti S.E., Muratani M., Wijnen H., Futcher B., Tansey W.P. Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis. Proc. Natl. Acad. Sci. USA. 97:2000;3118-3123.
43. Salghetti S.E., Caudy A.A., Chenoweth J.G., Tansey W.P. Regulation of transcriptional activation domain function by ubiquitin. Science. 293:2001;1651-1653.
44. Sears R., Leone G., DeGregori J., Nevins J.R. Ras enhances Myc protein stability. Mol. Cell. 3:1999;169-179.
45. Sheiness D., Bishop J.M. DNA and RNA from uninfected vertebrate cells contain nucleotide sequences related to the putative transforming gene of avian myelocytomatosis virus. J. Virol. 31:1979;514-521.
46. Spencer C.A., Groudine M. Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56:1991;1-48.
47. Spruck C., Strohmaier H., Watson M., Smith A.P., Ryan A., Krek T.W., Reed S.I. A CDK-independent function of mammalian Cks1. targeting of SCF(Skp2) to the CDK inhibitor p27Kip1 Mol. Cell. 7:2001;639-650.
48. Sutterluty H., Chatelain E., Marti A., Wirbelauer C., Senften M., Muller U., Krek W. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat. Cell Biol. 1:1999;207-214.
49. Tanaka M. Modulation of promoter occupancy by cooperative DNA binding and activation-domain function is a major determinant of transcriptional regulation by activators in vivo. Proc. Natl. Acad. Sci. USA. 93:1996;4311-4315.
50. Treier M., Staszewski L.M., Bohmann D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell. 78:1994;787-798.
51. Wilson A.C., Freiman R.N., Goto H., Nishimoto T., Herr W. VP16 targets an amino-terminal domain of HCF involved in cell cycle progression. Mol. Cell. Biol. 17:1997;6139-6146.
52. Winston J.T., Koepp D.M., Zhu C., Elledge S.J., Harper J.W. A family of mammalian F-box proteins. Curr. Biol. 9:1999;1180-1182.
53. Zhang H., Kobayashi R., Galaktionov K., Beach D. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell. 82:1995;915-925.